Quick Answer
Cannabis Bioscience International Holdings, Inc. reported Net Income of -$548.8 thousand for fiscal year 2025.
Cannabis Bioscience International Holdings, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$548.8K | +15.7% |
| 2024 | -$651.3K | +36.9% |
| 2023 | -$1.03M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| November 30, 2025 | -$117.0K | -47.1% | -41.5% |
| August 31, 2025 | -$82.6K | -8.3% | -3.9% |
| November 30, 2024 | -$79.5K | +36.1% | -4.2% |
| August 31, 2024 | -$76.3K | +58.0% | +63.5% |
| February 29, 2024 | -$209.2K | +35.6% | -68.1% |
| November 30, 2023 | -$124.4K | +43.4% | +31.6% |
| August 31, 2023 | -$181.8K | +14.3% | +44.0% |
| February 28, 2023 | -$324.7K | — | -47.6% |
- Cannabis Bioscience International Holdings, Inc. showed an increase of +15.7% in Net Income compared to the prior fiscal year.
- Over the 2023–2025 period, Cannabis Bioscience International Holdings, Inc.’s net income has grown by 46.8% (from -$1.03 million to -$548.8 thousand).
- The most recent figure is from Cannabis Bioscience International Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 22, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: